Basic Information
LncRNA/CircRNA Name | circ_0033155 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | RT??PCR, Cell proliferation assay, Colony formation assay, Migration assay, Western blot |
Sample | NSCLC tissues, NSCLC cell lines HCC827 and H1975, normal bronchus epithelium cell line BEAS??B and NSCLC cell lines PC9 and H1650 |
Expression Pattern | down-regulated |
Function Description | the expression level of hsa_circ_0033155 was significantly downregulated in NSCLC tissue and the expression of hsa_circ_0033155 correlated with lymphatic metastasis. In order to further investigate the possible role of hsa_circ_0033155 in NSCLC progression, circRNA was overexpressed in NSCLC cells and it was observed that the overexpression of hsa_circ_0033155 significantly decreased cell proliferation, colony formation and migration, and elevated the level of phosphatase and tensin homolog deleted on chromosome 10, a tumor suppressor in many types of tumor. |
Pubmed ID | 30214545 |
Year | 2018 |
Title | Hsa_circ_0033155: A potential novel biomarker for non??mall cell lung cancer |
External Links
Links for circ_0033155 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |